Document Detail


Treatment of premature calves with clinically diagnosed respiratory distress syndrome.
MedLine Citation:
PMID:  18371034     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Respiratory distress syndrome (RDS) has been reported previously in premature calves. However, there have been no published data on the effect of surfactant replacement therapy in the treatment of premature calves with RDS. HYPOTHESIS: Surfactant replacement therapy added to the standard treatment for premature calves clinically diagnosed with RDS would increase the viability of the calves. ANIMALS: Twenty-seven premature calves with clinically diagnosed RDS. METHODS: Twenty calves were instilled intratracheally with bovine lung surfactant extract and provided with standard treatment for RDS (surfactant group). Seven calves were given only standard care for RDS without surfactant therapy and placed in the control group. Standard treatment for newborn calves with RDS includes warming, administration of intranasal oxygen, fluid replacement, administration of antibiotics, and immunoglobulin solution. Arterial blood samples were collected from the calves at 3 observation points, the first just before treatment (hour 0) and at 2 hours (hour 2) and 24 hours (hour 24) after treatment was started to determine if ventilation was adequate, improving, or deteriorating. Blood gases, pH, bicarbonate, and lactate concentrations were measured. RESULTS: In the surfactant group, mean partial pressure of oxygen significantly increased at hours 2 and 24. Mean partial pressure of carbon dioxide decreased and mean arterial blood pH increased at hour 24 in the surfactant group compared with the control group (P < .05). Of the 20 calves in the surfactant group, 12 survived and 8 died. All 7 calves in the control group died. CONCLUSIONS AND CLINICAL IMPORTANCE: The results of this study suggest that surfactant replacement therapy may reduce neonatal deaths in premature calves with clinically diagnosed RDS.
Authors:
T Karapinar; M Dabak
Related Documents :
19764904 - Effects of surfactant replacement on alveolar overdistension and plasma cytokines in ve...
1174314 - Hyperbaric oxygen and pulmonary surface tension.
581094 - Effects of tracheal instillation of natural surfactant in premature lambs. i. clinical ...
2540144 - Unilateral radiation pneumonitis in sheep: physiological changes and bronchoalveolar la...
17947504 - Spleen and cardiovascular function during short apneas in divers.
3971834 - Endoscopic manometry of the pancreatic duct and sphincter zone in patients with chronic...
Publication Detail:
Type:  Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of veterinary internal medicine / American College of Veterinary Internal Medicine     Volume:  22     ISSN:  0891-6640     ISO Abbreviation:  J. Vet. Intern. Med.     Publication Date:    2008 Mar-Apr
Date Detail:
Created Date:  2008-03-28     Completed Date:  2008-09-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8708660     Medline TA:  J Vet Intern Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  462-6     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, Veterinary Faculty, Firat University, Elazig, Turkey. tolgakarapinar@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Animals, Newborn
Cattle
Cattle Diseases / therapy*
Female
Humans
Infant, Newborn
Pregnancy
Premature Birth / veterinary
Prospective Studies
Pulmonary Surfactants / therapeutic use*
Respiratory Distress Syndrome, Newborn / drug therapy,  veterinary*
Chemical
Reg. No./Substance:
0/Pulmonary Surfactants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Thrombotic endocarditis in 10 alpacas.
Next Document:  Cavernosometry: is it a dinosaur?